|
⚲
|
| Keyboard |
| Angermayer Christian
✚
|
|
|---|---|
| CIK # | 0001845872 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001845872] | |
| 4 | [0001845872] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Atai Beckley NV ATAI
Convertible Notes · derivative
|
2025-09-30 | Conversion | 147,950 | ||
|
Atai Beckley NV ATAI
Common Shares
|
2025-09-30 | Conversion | 2,367,200 | ||
|
Atai Beckley NV ATAI
Common Shares
|
2025-08-14 | Buy | 8,675,799 | $2.19 | 19,000,000 |
|
Atai Beckley NV ATAI
Stock Option · derivative
|
2025-06-26 | Grant | 103,000 | $0.00 | |
|
Atai Beckley NV ATAI
Stock Option · derivative
|
2025-06-02 | Grant | 131,698 | ||
|
Atai Beckley NV ATAI
Common Shares
|
2025-03-24 | Buy | 1,800,000 | $1.40 | 2,520,000 |
|
Atai Beckley NV ATAI
Common Shares
|
2025-02-14 | Buy | 10,835,718 | $2.10 | 22,755,008 |
|
Atai Beckley NV ATAI
Stock Option · derivative
|
2024-10-04 | Grant | 624,000 | ||
|
Bionomics Ltd/ADR BNOX
Ordinary Shares
|
2024-10-04 | Sell | 557 | $0.28 | 156 |
|
Atai Beckley NV ATAI
Stock Option · derivative
|
2024-10-04 | Disposed to issuer | 624,000 | ||
|
Bionomics Ltd/ADR BNOX
Ordinary Shares
|
2024-10-03 | Sell | 180,707 | $0.29 | 52,405 |
|
Bionomics Ltd/ADR BNOX
Ordinary Shares
|
2024-10-02 | Sell | 90,806 | $0.33 | 29,966 |
|
Atai Beckley NV ATAI
Stock Option · derivative
|
2024-06-13 | Grant | 103,000 | $0.00 | |
|
Atai Beckley NV ATAI
Convertible Notes · derivative
|
2024-04-15 | Other | 147,950 | ||
|
Atai Beckley NV ATAI
Convertible Notes · derivative
|
2024-04-15 | Other | 147,950 | ||
|
Alto Neuroscience Inc ANRO
Common Stock
|
2024-02-06 | Conversion | 674,658 | ||
|
Alto Neuroscience Inc ANRO
Series A Preferred Stock · derivative
|
2024-02-06 | Conversion | 1,063,918 | ||
|
Alto Neuroscience Inc ANRO
Warrants to Purchase Series A Preferred Stock · derivative
|
2024-02-06 | Conversion | 444,561 | ||
|
Alto Neuroscience Inc ANRO
Series B Preferred Stock · derivative
|
2024-02-06 | Conversion | 416,665 | ||
|
Alto Neuroscience Inc ANRO
Series A Preferred Stock · derivative
|
2024-02-06 | Conversion | 406,072 | ||
| showing 20 of 46 most recent transactions | |||||